Candice Bertsch, CRNP

Candice Bertsch practices at Dothan Hematology & Oncology in Dothan, Alabama.

Candice Bertsch's NPI, 1841920030, was assigned on June 13, 2022. Candice Bertsch holds Alabama license 1-121859.

Candice Bertsch's primary practice is Dothan Hematology & Oncology, at 287 Healthwest Dr, Dothan, AL 36303 in Houston County. The practice phone is (334) 792-9500.

Candice Bertsch's primary practice is Dothan Hematology & Oncology in Dothan, Alabama. Candice Bertsch is also affiliated with Southeast Health Medical Center. The medical group on file is Dothan Hematology & Oncology. Dmand AI also links Candice Bertsch to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Candice Bertsch practices, 5 sites in all. Vendor and product names are available with a free account.

Family is Candice Bertsch's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Candice Bertsch is licensed in Alabama.

Dmand AI lists osteoporosis among the conditions Candice Bertsch treats.

CMS data shows 189 Medicare services from Candice Bertsch across 2 procedure codes in 2024, all of them office visits, for 149 Medicare patients. Medicare paid $12,132 for them. Every service was in an office.

CMS counts 149 Medicare patients who saw Candice Bertsch in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Candice Bertsch's median patient age at 64, with 63% women.

In 2024, Candice Bertsch wrote 262 Medicare Part D claims for 88 patients. 94% of them were for generic drugs. CMS names the drug for 196 of them, across 9 drugs with 11 or more claims each, at $3,709 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Candice Bertsch for performance year 2024, reported as part of a group. Candice Bertsch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 258 general payments to Candice Bertsch from 58 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 99% of the total. Incyte Corporation paid the most, $445.